US Stock MarketDetailed Quotes

FENC Fennec Pharmaceuticals

Watchlist
  • 6.250
  • +0.320+5.40%
Close Aug 12 16:00 ET
  • 6.250
  • 0.0000.00%
Post 16:13 ET
170.76MMarket Cap156.25P/E (TTM)

About Fennec Pharmaceuticals Company

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Company Profile

SymbolFENC
Company NameFennec Pharmaceuticals
Listing DateSep 13, 2017
Founded1996
CEOMr. Jeffrey S. Hackman
MarketNASDAQ
Employees29
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressResearch Triangle Park,68 T.W. Alexander Drive
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27709
Phone1-919-636-4530
Websitehttp://www.fennecpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Jeffrey S. Hackman
  • Chief Executive Officer and Director
  • --
  • Robert Andrade
  • Chief Financial Officer and Principal Accounting Officer
  • 1.31M
  • Dr. Khalid Islam, PhD
  • Chairman of the Board
  • 225.23K
  • Rostislav Raykov
  • Director
  • 2.54M
  • Dr. Jodi A. Cook, PhD
  • Independent Director
  • 153.81K
  • Chris A. Rallis
  • Independent Director
  • 173.18K
  • Dr. Marco M. Brughera
  • Independent Director
  • 166.31K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg